… repigmentation in patients with vitiligo at 1 year, regardless … years) with non-segmental vitiligo received 1.5% ruxolitinib cream … from baseline in facial Vitiligo Area Scoring Index (F … and adult patients with vitiligo applying ruxolitinib cream could …

… Inhibitors and the Risk of Vitiligo: A Mendelian Randomization Study,” … largest meta-analysis available for vitiligo, the Global Lipids Genetics Consortium … genetically proxied protective effects against vitiligo were identified using lipid-lowering …

… Treatment,” explored various aspects of vitiligo management through case-based … , and emerging therapies. Understanding Vitiligo Experts started by discussing the … patient communication is crucial in vitiligo management. Clinicians emphasized the …

… 10 years, living with the vitiligo on the visible parts of … identity within other people with vitiligo. “It's a stress …

… developing these in patients with vitiligo compared to matched controls, … , 30,130 patients with vitiligo, 90,388 matched controls, … events among patients with vitiligo may help inform treatment … Malignancies Among Patients With Vitiligo in the United States …

… following ASCS treatment for stable vitiligo.   They treated 107 individuals … Fitzpatrick skin types, and major vitiligo subtypes were included. Excellent repigmentation … 8% achieved complete repigmentation. The Vitiligo Noticeability Scale response was met …

… survey of pediatric patients with vitiligo, only 51.4% were … of 111 pediatric patients with vitiligo (mean age at diagnosis, … phototherapy, used to manage vitiligo that is widespread or spreading … . “As novel therapies for vitiligo emerge, it is important to …

… candidate, as a therapy for vitiligo, a common autoimmune disorder that …

… candidate, as a therapy for vitiligo, a common autoimmune disorder that …

… in soft-tissue reconstruction and vitiligo underway. It is currently in …